Objective Thyroglobulin measurement is the cornerstone of modern management of
differentiated thyroid cancer, with clinical decisions on treatment and follow-up based on the …

At present, no European recommendations for the management of pediatric thyroid nodules
and differentiated thyroid carcinoma (DTC) exist. Differences in clinical, molecular, and …

Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Background: Biotin has been reported to interfere with several commonly used laboratory
assays resulting in misleading values and possible erroneous diagnosis and treatment. This …

The use of recombinant human thyrotropin (rhTSH) testing in the diagnosis and therapy of
differentiated thyroid cancer (DTC) has been adopted over the last two decades as an …

Background Predicting the possibility of ipsilateral lateral cervical lymph node metastasis
(ipsi-LLNM) was crucial to the operation plan for patients with papillary thyroid carcinoma …

Objective Thyroglobulin (Tg) is an established tumor marker for differentiated thyroid
carcinoma (DTC) patients. However, Tg immunoassays can be subject to Tg autoantibody …

Objective High-sensitive thyroglobulin assays (hsTg) has decreased the need for stimulated
Tg measurements in patients with differentiated thyroid carcinoma (DTC). However, multiple …

Background: Thyroglobulin (Tg) is an established tumor marker in differentiated thyroid
carcinoma (DTC). However, Tg assays can be subject to interference by autoantibodies …

Thyroglobulin (Tg) is an important index for the surveillance of differentiated thyroid
carcinoma, and yet sensitive and specific protein detection still faces challenges in both …